99651-65-7

Basic information

• Product Name: 1,2-Propanediol, 3-(dodecyloxy)-, (S)-
• Synonyms: (S)-3-Dodecyloxy-propane-1,2-diol;(S)-dodecyloxypropane-1,2-diol;1-O-Dodecyl-sn-glycerol;1-O-lauryl-sn-glycerol;(S)-1-dodecyl-glycerol;(S)-3-(dodecyloxy)propane-1,2-diol
• CAS NO: 99651-65-7
• Molecular Formula: C15H32O3
• Molecular Weight: 260.417
• Mol File: 99651-65-7.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 390.5±22.0 °C(Predicted)
• Density: 0.937±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1,2-Propanediol, 3-(dodecyloxy)-, (S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,2-Propanediol, 3-(dodecyloxy)-, (S)-(99651-65-7)
• EPA Substance Registry System: 1,2-Propanediol, 3-(dodecyloxy)-, (S)-(99651-65-7)

Safety Data

• Hazardous Substances Data: 99651-65-7(Hazardous Substances Data)

Usage

Uses

1-O-Dodecyl-sn-glycerol is used to prepare lysophosphatidylcholine (LPC) analogs in the study of autotaxin structure-activity relationships. It is also used to prepare cysteine based lipopeptides as TLR2 agonists.

Upstream product

• 143-15-7 1-dodecylbromide 
• 14347-78-5 1,2-O-isopropylidene-D-glycerol 
• 112-53-8 1-dodecyl alcohol 
• 60456-23-7 (S)-oxiranemethanol 
• 1731-88-0 methyl tridecanoate 
• 51323-71-8 dodecyl mesylate 
• 91423-46-0 (S)-3-(dodeca-1,3,5,7,9-pentaenyloxy)propane-1,2-diol 

Downstream Products

• 1305349-90-9 (R)-1-dodecyl-3-trityl-glycerol 
• 99651-71-5 (R)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (R)-1-dodecyloxymethyl-2-((R)-3,3,3-trifluoro-2-methoxy-2-phenyl-propionyloxy)-ethyl ester 

Relevant articles and documents

Enantiomeric synthesis of natural alkylglycerols and their antibacterial and antibiofilm activities

Alkylglycerols (AKGs) are bioactive natural compounds that vary by alkyl chain length and degree of unsaturation, and their absolute configuration is 2S. Three AKGs (5l–5n) were synthesised in enantiomerically pure form, and were characterised for the first time together with 12 other known and naturally occurring AKGs (5a–5k, 5o). Their structures were established using 1H and 13C APT NMR with 2D-NMR, ESI-MS or HRESI-MS and optical rotation data, and they were tested for their antibacterial and antibiofilm activities. AKGs 5a–5m and 5o showed activity against five clinical isolates and P. aeruginosa ATCC 15442, with MIC values in the range of 15–125 μg/mL. In addition, at half of the MIC, most of the AKGs reduced S. aureus biofilm formation in the range of 23%–99% and P. aeruginosa ATCC 15442 biofilm formation in the range of 14%–64%. The antibiofilm activity of the AKGs assessed in this work had not previously been studied.

Autotaxin structure-activity relationships revealed through lysophosphatidylcholine analogs

Autotaxin (ATX) catalyzes the hydrolysis of lysophosphatidylcholine (LPC) to form the bioactive lipid lysophosphatidic acid (LPA). LPA stimulates cell proliferation, cell survival, and cell migration and is involved in obesity, rheumatoid arthritis, neuropathic pain, atherosclerosis and various cancers, suggesting that ATX inhibitors have broad therapeutic potential. Product feedback inhibition of ATX by LPA has stimulated structure-activity studies focused on LPA analogs. However, LPA displays mixed mode inhibition, indicating that it can bind to both the enzyme and the enzyme-substrate complex. This suggests that LPA may not interact solely with the catalytic site. In this report we have prepared LPC analogs to help map out substrate structure-activity relationships. The structural variances include length and unsaturation of the fatty tail, choline and polar linker presence, acyl versus ether linkage of the hydrocarbon chain, and methylene and nitrogen replacement of the choline oxygen. All LPC analogs were assayed in competition with the synthetic substrate, FS-3, to show the preference ATX has for each alteration. Choline presence and methylene replacement of the choline oxygen were detrimental to ATX recognition. These findings provide insights into the structure of the enzyme in the vicinity of the catalytic site as well as suggesting that ATX produces rate enhancement, at least in part, by substrate destabilization.

Structure Elucidation of a Potent Mutagen from Human Feces

-